(Q40444813)

20 September 2017

1 reference

title

Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences (English)

1 reference

20 September 2017

Kramer MD

1 reference

20 September 2017

Schaefer B

series ordinal

1 reference

20 September 2017

Reinartz J

series ordinal

1 reference

20 September 2017

publication date

1 March 1995

1 reference

Biological chemistry Hoppe-Seyler

20 September 2017

published in

1 reference

20 September 2017

volume

376

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

131-141

1 reference

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen binding sites in normal human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen is present in the basal layer of the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Tissue plasminogen activator in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Epidermal plasminogen activator activity, tPA-dependent, is a marker of disease activity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Enzymatic properties of the one- and two-chain form of tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Binding and activation of plasminogen at the surface of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Differential protease expression by cutaneous squamous and basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Autocrine saturation of pro-urokinase receptors on human A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The plasminogen activator/plasmin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

On the Primary Structure of Human Plasminogen and Plasmin. Purification and Characterization of Cyanogen-Bromide Fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen activator inhibitors: hormonally regulated serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Tyrosine phosphorylation of human urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Modulation of surface-associated urokinase: Binding, interiorization, delivery to lysosomes, and degradation in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Glycosaminoglycans on fibroblasts accelerate thrombin inhibition by protease nexin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The urokinase receptor is required for human monocyte chemotaxis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

In migrating fibroblasts, recycling receptors are concentrated in narrow tubules in the pericentriolar area, and then routed to the plasma membrane of the leading lamella

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Growth Factors in the Regulation of Plasminogen-Plasmin System in Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Immunocytochemical identification of the human alpha 2-macroglobulin receptor in monocytes and fibroblasts: monoclonal antibodies define the receptor as a monocyte differentiation antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Upregulation of urokinase receptor expression on migrating endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The receptor for the plasminogen activator of urokinase type is up-regulated in transformed rat thyroid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Processing of complex between urokinase and its type-2 inhibitor on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Primary amines inhibit recycling of α2M receptors in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.3.131

10.1515/BCHM3.1995.376.3.131

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference